Marinus Pharma

Marinus Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of patients suffering from seizure disorders. Their focus is on developing innovative treatment options, primarily using their lead drug candidate, ganaxolone. This drug, designed to modulate the GABA receptor, is being developed in both intravenous and oral formulations, aiming to provide treatment for both acute and chronic care settings, as well as for both adult and pediatric patients. Marinus prioritizes collaboration with patients, caregivers, healthcare professionals, and advocacy organizations, recognizing the diverse perspectives and shared commitment needed to achieve progress.

Beyond drug development, Marinus demonstrates a strong commitment to the epilepsy community through various initiatives. They provide educational grants and sponsorships to support research and awareness, and actively engage with patient advocacy groups to gain valuable insights and support the development process. They also offer access programs for patients who may not be eligible for clinical trials, demonstrating a focus on patient well-being and accessibility. Marinus' mission is fueled by a desire to transform medicine for those living with seizure disorders, ensuring that patients have access to the best possible care and treatment options.

Marinus Pharmaceuticals offers employees the flexibility to work from anywhere, whether they are early, mid, or late career and live in a variety of locations. The company is committed to fostering a diverse and inclusive environment where employees feel empowered to achieve their full potential.

Marinus Pharmaceuticals offers a comprehensive benefits package designed to support the well-being of their employees. Benefits include health insurance with options for medical, dental, and vision coverage, as well as life insurance, disability insurance, and paid time off. The company also provides a 401(k) retirement savings plan with a company match, and opportunities for professional development through training and education programs.

Marinus Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of patients with seizure disorders through the development of innovative treatment options. They are committed to collaborating closely with patients, caregivers, and healthcare professionals to provide much-needed options for patients, embracing the challenge of developing treatments for seizure disorders with a strong scientific rationale, determination, and expertise. Their vision is to strengthen the treatment landscape for children and adults afflicted with seizure disorders.

Marinus Pharmaceuticals promotes a culture that prioritizes patient well-being, driven by a commitment to innovation and collaboration. They foster a diverse and inclusive environment where employees feel empowered to achieve their full potential, actively seek out new ways to learn from patients and their families, support advocacy partners, and give back to the community. Their core values of commitment, innovation, and collaboration are deeply embedded in their culture, creating a welcoming and supportive workplace.

Marinus Pharmaceuticals is dedicated to fostering a diverse and inclusive workplace, believing that it strengthens innovation and creates a stronger sense of community. Their commitment to diversity, equity, and inclusion (DEI) is evident in their collaborative approach to crafting a DEI mission statement, which involved input from all levels of the organization. Marinus emphasizes valuing diverse backgrounds and experiences, fostering a team-oriented, inclusive, and accountable environment where everyone feels welcome, respected, and empowered to contribute.